Trials / Conditions / Essential Fatty Acid Deficiency (EFAD)
Essential Fatty Acid Deficiency (EFAD)
3 registered clinical trials studyying Essential Fatty Acid Deficiency (EFAD) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients NCT06049680 | Fresenius Kabi | Phase 4 |
| Completed | Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or St NCT04555044 | Baxter Healthcare Corporation | Phase 4 |
| Terminated | Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or St NCT02476994 | Baxter Healthcare Corporation | Phase 4 |